Identifying hemophilia B carriers: Utility of aPTT, factor IX levels and ratios of factor IX to other Vitamin K dependent factors
- PMID: 38924261
- DOI: 10.1111/hae.15068
Identifying hemophilia B carriers: Utility of aPTT, factor IX levels and ratios of factor IX to other Vitamin K dependent factors
Abstract
Introduction: Diagnosing hemophilia B (HB) carrier status is important to manage bleeding in carriers and to prevent bleeding in potential offspring. Without a family history of hemophilia, diagnosing HB carrier status is challenging. Genetic testing is the gold-standard, however it is reserved for individuals with a high suspicion of carrier status.
Aims: To describe the distribution of activated partial thromboplastin time (aPTT) and factor IX coagulant (FIX:C) levels in HB carriers and assess the ratio of FIX:C to other Vitamin K dependent factors (FII:C, FVII:C, FX:C) as an indicator of HB carrier status.
Methods: In this retrospective, single-centre cohort study, subjects were included if they were obligate or genetically proven HB carriers. Distributions of aPTT and FIX:C were described and the relationship between FIX:C levels in carriers and severity of familial HB was analysed. Ratios of FIX:C to FII:C, FVII:C, FX:C were calculated.
Results: Seventy-two female HB carriers (median age: 34 years; IQR 24-43) were included. Median aPTT and FIX:C levels were 33.0 s [IQR 30.0-37.0] and 57 IU/dL [IQR 43-74]. Fifteen carriers (21%) had mild HB (FIX:C levels of 10-40 IU/dL). FIX:C levels trended higher in carriers of mild HB versus carriers of moderate/severe HB. In six carriers, the median ratio of FIX:C to other Vitamin K dependent factors was 0.44, with 92% of ratios being ≤ 0.75.
Conclusion: aPTT and FIX:C levels were unreliable in diagnosing HB carrier status. A low ratio of FIX:C to other Vitamin K dependent factors may be a useful marker of HB carrier status.
Keywords: activated partial thromboplastin time; blood coagulation factors; factor IX; genetic carrier screening; hemophilia B.
© 2024 The Author(s). Haemophilia published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Carcao MD. The diagnosis and management of congenital hemophilia. Semin Thromb Hemost. 2012;38(7):727‐734.
-
- Chaigneau M, Botros M, Grabell J, Hopman W, James P. Challenges and knowledge gaps facing hemophilia carriers today: perspectives from patients and health care providers. Res Pract Thromb Haemost. 2022;6(6):e12783.
-
- James PD, Mahlangu J, Bidlingmaier C, et al. Evaluation of the utility of the ISTH‐BAT in haemophilia carriers: a multinational study. Haemophilia. 2016;22(6):912‐918.
-
- Chaudhury A, Sidonio R Jr, Jain N, et al. Women and girls with haemophilia and bleeding tendencies: outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review. Haemophilia. 2021;27(2):293‐304.
-
- Staber J, Croteau SE, Davis J, Grabowski EF, Kouides P, Sidonio Jr RF. The spectrum of bleeding in women and girls with haemophilia B. Haemophilia. 2018;24(2):180‐185.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical